Literature DB >> 12393968

Fetal tobacco syndrome and perinatal outcome.

Dubravko Habek1, Jasna Cerkez Habek, Marina Ivanisević, Josip Djelmis.   

Abstract

OBJECTIVE: The aim of this study was to evaluate perinatal outcome in newborns of mothers who are smokers.
METHODS: The study included 87 pregnant women with a single pregnancy in the cephalic position, 64 of them nonsmokers (group 1), 13 who smoked 5-20 cigarettes per day (group 2) and 10 who smoked more than 20 cigarettes per day (group 3). Maternal demographic variables and laboratory hemoglobin concentration, hematocrit and erythrocyte count in the last trimester were recorded. Perinatal outcome included type of delivery (vaginal or cesarean section), birth weight, occurrence of meconium in the amniotic fluid, 5-min Apgar score, umbilical arterial blood pH postpartum, sex of the newborn, need for treatment at a neonatal intensive care unit (NICU) and clinically and neurosonographically verified postpartum neurologic complications in the newborn.
RESULTS: A statistically significant correlation (p < 0.01) was found with the mean gestational age at delivery in all three groups of women, especially in those smoking >20 cigarettes per day, who had a higher incidence of premature deliveries. Maternal laboratory findings also differed significantly among the three groups of women, i.e. erythrocyte count (p < 0.01), hemoglobin concentration (p < 0.01) and hematocrit (p < 0.001). The rate of delivery by cesarean section was significantly higher in the groups of smokers, irrespective of the number of cigarettes per day (groups 2 and 3). Birth weight was lower by about 250 and 350 g (p < 0.001) in groups 2 and 3, respectively. Five-minute Apgar score and umbilical arterial blood pH were lower in group 3 as compared with groups 1 and 2 (p < 0.01). NICU treatment was required in more than 50% of infants born to group 3 mothers, in whom 70% of perinatal neurologic complications such as subependymal hemorrhage, periventricular hemorrhage, porencephalic cysts, intracranial hemorrhage and swallowing disturbance of the newborn were recorded (p < 0.001). The infants born to group 3 mothers had a longer and more difficult period of adaptation, thus often requiring an NICU stay.
CONCLUSION: Our study confirmed that pregnancy burdened with smoking, especially in the case of >20 cigarettes a day, is associated with a high risk due to the development of maternal anemia and fetal hypoxia and polyglobulia, which in turn result in a significantly poorer perinatal outcome in infants born to smoking mothers and compromised subsequent development of the child, as evidenced by the morphological substrates on the brain resulting from the fetal mechanism of defense against hypoxia. Clinically, there was no other (etiologic) reason for (chronic) fetal hypoxia; thus, the clinical substrate of fetal tobacco syndrome could be presumed to have developed consequentially to chronic smoking during pregnancy, as a preuterine factor of fetal hypoxia. Other gestational or gestation-related diseases (e.g., gestosis, diabetes) that may potentially cause nutritional and respiratory insufficiency of the placenta were ruled out. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12393968     DOI: 10.1159/000065387

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  17 in total

1.  Infant birth outcomes among substance using women: why quitting smoking during pregnancy is just as important as quitting illicit drug use.

Authors:  Beth A Bailey; Judy G McCook; Alexis Hodge; Lana McGrady
Journal:  Matern Child Health J       Date:  2012-02

2.  Prenatal nicotine exposure in rhesus monkeys compromises development of brainstem and cardiac monoamine pathways involved in perinatal adaptation and sudden infant death syndrome: amelioration by vitamin C.

Authors:  Theodore A Slotkin; Frederic J Seidler; Eliot R Spindel
Journal:  Neurotoxicol Teratol       Date:  2011-02-12       Impact factor: 3.763

3.  The relationship of gestational smoking with pregnancy complications and sociodemographic characteristics of mothers.

Authors:  Ayşen Kutan Fenercioğlu; Gazi Yıldırım; Güner Karatekin; Nimet Göker
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

4.  Apgar score and hospitalization for epilepsy in childhood: a registry-based cohort study.

Authors:  Vera Ehrenstein; Henrik T Sørensen; Lars Pedersen; Helle Larsen; Vibeke Holsteen; Kenneth J Rothman
Journal:  BMC Public Health       Date:  2006-02-01       Impact factor: 3.295

5.  Qualitatively and quantitatively similar effects of active and passive maternal tobacco smoke exposure on in utero mutagenesis at the HPRT locus.

Authors:  Stephen G Grant
Journal:  BMC Pediatr       Date:  2005-06-29       Impact factor: 2.125

6.  Caspase 3 activity in isolated fetal rat lung fibroblasts and rat periodontal ligament fibroblasts: cigarette smoke induced alterations.

Authors:  Asra Ahmed; James A Thliveris; Anthony Shaw; Michael Sowa; James Gilchrist; James E Scott
Journal:  Tob Induc Dis       Date:  2013-12-06       Impact factor: 2.600

7.  Hepcidin and Iron Metabolism in Pregnancy: Correlation with Smoking and Birth Weight and Length.

Authors:  Magdalena Chełchowska; Jadwiga Ambroszkiewicz; Joanna Gajewska; Ewa Jabłońska-Głąb; Tomasz M Maciejewski; Mariusz Ołtarzewski
Journal:  Biol Trace Elem Res       Date:  2016-01-20       Impact factor: 3.738

8.  Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants.

Authors:  Simon Kayemba-Kay's; Michael P P Geary; Jane Pringle; Charles H Rodeck; John C P Kingdom; Peter C Hindmarsh
Journal:  Eur J Endocrinol       Date:  2008-06-04       Impact factor: 6.664

9.  Effects of nicotine during pregnancy: human and experimental evidence.

Authors:  R Wickström
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

10.  Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats.

Authors:  Zein Shaban Ibrahim; Mohamed Elsayed Alkafafy; Mohamed Mohamed Ahmed; Mohamed Mohamed Soliman
Journal:  Mol Med Rep       Date:  2016-02-22       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.